AB
AH Bio Fund III, L.P.
DELAYED 1 MONTH
10% Owner
Scribe Therapeutics, Inc.
Filings
1
Companies
1
Latest
Jul 27, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Scribe Therapeutics, Inc.
AH Bio Fund III, L.P.
10% Owner
Purchase
$5.0M
333,333 sh
Jul 29 11:09 PM
Jul 27, 2026